Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Galtier

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Molecular Endocrinology (Baltimore, Md.)|January 30, 2003
Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effectCatherine Teyssier, Karine Belguise, Florence Galtier, et al.
Diabetes, Obesity & Metabolism|September 4, 2022
Larger effect size in composite kidney outcomes than in major cardiovascular events associated with sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with glucagon-like peptide-1 receptor agonists (GLP-1RAs): A pooled analysis of type 2 diabetes trialsAlhassane Diallo, Miguel Carlos-Bolumbu, Pr Eric Renard, et al.
Fundamental & Clinical Pharmacology|November 30, 2005
Pharmacological interventions that directly stimulate or modulate insulin secretion from pancreatic beta-cell: implications for the treatment of type 2 diabetesAnne Farret, Laura Lugo-Garcia, Florence Galtier, et al.
Diabetes, Obesity & Metabolism|June 25, 2025
Blood glucose and body weight reduction for the prevention of clinical events and mortality in patients with type 2 diabetes: A meta-analysis and meta-regression of 44 randomized controlled trialsAlhassane Diallo, Orianne Villard, Miguel Carlos-Bolumbu, et al.
Diabetes, Obesity & Metabolism|October 23, 2023
Effects of hypoglycaemic agents on reducing surrogate metabolic parameters for the prevention of cardiovascular events and death in patients with type 2 diabetes: A systematic review and meta-analysisAlhassane Diallo, Orianne Villard, Miguel Carlos-Bolumbu, et al.
European Journal of Clinical Pharmacology|October 8, 2009
A fenugreek seed extract selectively reduces spontaneous fat consumption in healthy volunteersHugues Chevassus, Nathalie Molinier, Françoise Costa, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 18, 2014
Nutrient deficiencies in patients with obesity considering bariatric surgery: a cross-sectional studyPatrick Lefebvre, Flavie Letois, Ariane Sultan, et al.
Fundamental & Clinical Pharmacology|August 19, 2009
Selecting healthy volunteers in specific populations: a retrospective analysis of clinical and laboratory screeningClarisse Roux, Hugues Chevassus, Anne Farret, et al.
Fertility and Sterility|August 9, 2011
Polycystic ovary-like syndrome in adolescent competitive swimmersOlivier Coste, Françoise Paris, Florence Galtier, et al.
Human Vaccines|September 23, 2011
Questions for biotechs: REIVACPierre Loulergue, Xavier Duval, Florence Galtier, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Molecular Endocrinology (Baltimore, Md.)|January 30, 2003
Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effectCatherine Teyssier, Karine Belguise, Florence Galtier, et al.
Diabetes, Obesity & Metabolism|September 4, 2022
Larger effect size in composite kidney outcomes than in major cardiovascular events associated with sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with glucagon-like peptide-1 receptor agonists (GLP-1RAs): A pooled analysis of type 2 diabetes trialsAlhassane Diallo, Miguel Carlos-Bolumbu, Pr Eric Renard, et al.
Fundamental & Clinical Pharmacology|November 30, 2005
Pharmacological interventions that directly stimulate or modulate insulin secretion from pancreatic beta-cell: implications for the treatment of type 2 diabetesAnne Farret, Laura Lugo-Garcia, Florence Galtier, et al.
Diabetes, Obesity & Metabolism|June 25, 2025
Blood glucose and body weight reduction for the prevention of clinical events and mortality in patients with type 2 diabetes: A meta-analysis and meta-regression of 44 randomized controlled trialsAlhassane Diallo, Orianne Villard, Miguel Carlos-Bolumbu, et al.
Diabetes, Obesity & Metabolism|October 23, 2023
Effects of hypoglycaemic agents on reducing surrogate metabolic parameters for the prevention of cardiovascular events and death in patients with type 2 diabetes: A systematic review and meta-analysisAlhassane Diallo, Orianne Villard, Miguel Carlos-Bolumbu, et al.
European Journal of Clinical Pharmacology|October 8, 2009
A fenugreek seed extract selectively reduces spontaneous fat consumption in healthy volunteersHugues Chevassus, Nathalie Molinier, Françoise Costa, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 18, 2014
Nutrient deficiencies in patients with obesity considering bariatric surgery: a cross-sectional studyPatrick Lefebvre, Flavie Letois, Ariane Sultan, et al.
Fundamental & Clinical Pharmacology|August 19, 2009
Selecting healthy volunteers in specific populations: a retrospective analysis of clinical and laboratory screeningClarisse Roux, Hugues Chevassus, Anne Farret, et al.
Fertility and Sterility|August 9, 2011
Polycystic ovary-like syndrome in adolescent competitive swimmersOlivier Coste, Françoise Paris, Florence Galtier, et al.
Human Vaccines|September 23, 2011
Questions for biotechs: REIVACPierre Loulergue, Xavier Duval, Florence Galtier, et al.
Pageof 8